Technical Strategy for Pancreatic Body Cancers: A Raison d'etre of Distal Pancreatectomy with Portal Resection.
Distal pancreatectomy
Pancreatic body cancer
Pancreaticoduodenectomy
Portal vein resection
Surgical indication
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
11 Nov 2023
11 Nov 2023
Historique:
received:
19
07
2023
accepted:
22
10
2023
medline:
12
11
2023
pubmed:
12
11
2023
entrez:
11
11
2023
Statut:
aheadofprint
Résumé
Advancements in multiagent chemotherapy have expanded the surgical indications for pancreatic cancer. Although pancreaticoduodenectomy (PD) with portal vein resection (PVR) has become widely adopted, distal pancreatectomy (DP) with PVR remains rarely performed because of its technical complexity. This study was designed to assess the feasibility of DP-PVR compared with PD-PVR for pancreatic body cancers, with a focus on PV complications and providing optimal reconstruction techniques when DP-PVR is necessary. A retrospective review was conducted on consecutive pancreatic body cancer patients who underwent pancreatectomy with PVR between 2005 and 2020. An algorithm based on the anatomical relationship between the arteries and PV was used for optimal surgical selection. Among 119 patients, 32 underwent DP-PVR and 87 underwent PD-PVR. Various reconstruction techniques were employed in DP-PVR cases, including patch reconstruction, graft interposition, and wedge resection. The majority of PD-PVR cases involved end-to-end anastomosis. The length of PVR was shorter in DP-PVR (25 vs. 40 mm; p < 0.001). Although Clavien-Dindo ≥3a was higher in DP-PVR (p = 0.002), inpatient mortality and R0 status were similar. Complete PV occlusion occurred more frequently in DP-PVR than in PD-PVR (21.9% vs. 1.1%; p < 0.001). A cutoff value of 30 mm for PVR length was determined to be predictive of nonrecurrence-related PV occlusion after DP-PVR. The two groups did not differ significantly in recurrence or overall survival. DP-PVR had higher occlusion and postoperative complication rates than PD-PVR. These findings support the proposed algorithm and emphasize the importance of meticulous surgical manipulation when DP-PVR is deemed necessary.
Sections du résumé
BACKGROUND
BACKGROUND
Advancements in multiagent chemotherapy have expanded the surgical indications for pancreatic cancer. Although pancreaticoduodenectomy (PD) with portal vein resection (PVR) has become widely adopted, distal pancreatectomy (DP) with PVR remains rarely performed because of its technical complexity. This study was designed to assess the feasibility of DP-PVR compared with PD-PVR for pancreatic body cancers, with a focus on PV complications and providing optimal reconstruction techniques when DP-PVR is necessary.
METHODS
METHODS
A retrospective review was conducted on consecutive pancreatic body cancer patients who underwent pancreatectomy with PVR between 2005 and 2020. An algorithm based on the anatomical relationship between the arteries and PV was used for optimal surgical selection.
RESULTS
RESULTS
Among 119 patients, 32 underwent DP-PVR and 87 underwent PD-PVR. Various reconstruction techniques were employed in DP-PVR cases, including patch reconstruction, graft interposition, and wedge resection. The majority of PD-PVR cases involved end-to-end anastomosis. The length of PVR was shorter in DP-PVR (25 vs. 40 mm; p < 0.001). Although Clavien-Dindo ≥3a was higher in DP-PVR (p = 0.002), inpatient mortality and R0 status were similar. Complete PV occlusion occurred more frequently in DP-PVR than in PD-PVR (21.9% vs. 1.1%; p < 0.001). A cutoff value of 30 mm for PVR length was determined to be predictive of nonrecurrence-related PV occlusion after DP-PVR. The two groups did not differ significantly in recurrence or overall survival.
CONCLUSIONS
CONCLUSIONS
DP-PVR had higher occlusion and postoperative complication rates than PD-PVR. These findings support the proposed algorithm and emphasize the importance of meticulous surgical manipulation when DP-PVR is deemed necessary.
Identifiants
pubmed: 37952022
doi: 10.1245/s10434-023-14554-5
pii: 10.1245/s10434-023-14554-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. Society of Surgical Oncology.
Références
Machairas N, Raptis DA, Velazquez PS, et al. The impact of neoadjuvant treatment on survival in patients undergoing pancreatoduodenectomy with concomitant portomesenteric venous resection: an International Multicenter Analysis. Ann Surg. 2021;274(5):721–8. https://doi.org/10.1097/SLA.0000000000005132 .
doi: 10.1097/SLA.0000000000005132
pubmed: 34353988
Nagakawa Y, Jang JY, Kawai M, et al. Surgical outcomes of pancreatectomy with resection of the portal vein and/or superior mesenteric vein and jejunal vein for pancreatic head cancer: A multicenter study. Ann Surg. 2021. https://doi.org/10.1097/SLA.0000000000005330 .
doi: 10.1097/SLA.0000000000005330
pubmed: 34913900
Oba A, Ito H, Ono Y, et al. Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion. BJS Open. 2020;4(3):438–48. https://doi.org/10.1002/bjs5.50268 .
doi: 10.1002/bjs5.50268
pubmed: 32191395
pmcid: 7260410
Del Chiaro M, Segersvard R, Rangelova E, et al. Cattell-Braasch maneuver combined with artery-first approach for superior mesenteric-portal vein resection during pancreatectomy. J Gastrointest Surg. 2015;19(12):2264–8. https://doi.org/10.1007/s11605-015-2958-1 .
doi: 10.1007/s11605-015-2958-1
pubmed: 26423804
Raptis DA, Sanchez-Velazquez P, Machairas N, et al. Defining benchmark outcomes for pancreatoduodenectomy with portomesenteric venous resection. Ann Surg. 2020;272(5):731–7. https://doi.org/10.1097/SLA.0000000000004267 .
doi: 10.1097/SLA.0000000000004267
pubmed: 32889866
Oba A, Kato T, Inoue Y, et al. Extent of venous resection during pancreatectomy-finding the balance of technical possibility and feasibility. J Gastrointest Oncol. 2021;12(5):2495–502. https://doi.org/10.21037/jgo-21-129 .
doi: 10.21037/jgo-21-129
pubmed: 34790410
pmcid: 8576227
Strasberg SM, Sanchez LA, Hawkins WG, Fields RC, Linehan DC. Resection of tumors of the neck of the pancreas with venous invasion: the “Whipple at the Splenic Artery (WATSA)” procedure. J Gastrointest Surg. 2012;16(5):1048–54. https://doi.org/10.1007/s11605-012-1841-6 .
doi: 10.1007/s11605-012-1841-6
pubmed: 22399270
Hirono S, Kawai M, Tani M, et al. Indication for the use of an interposed graft during portal vein and/or superior mesenteric vein reconstruction in pancreatic resection based on perioperative outcomes. Langenbecks Arch Surg. 2014;399(4):461–71. https://doi.org/10.1007/s00423-014-1182-x .
doi: 10.1007/s00423-014-1182-x
pubmed: 24663295
Ohgi K, Sugiura T, Yamamoto Y, et al. Benign portal vein stenosis after pancreaticoduodenectomy. World J Surg. 2019;43(10):2623–30. https://doi.org/10.1007/s00268-019-05070-3 .
doi: 10.1007/s00268-019-05070-3
pubmed: 31243526
Fujii T, Nakao A, Yamada S, et al. Vein resections >3 cm during pancreatectomy are associated with poor 1-year patency rates. Surgery. 2015;157(4):708–15. https://doi.org/10.1016/j.surg.2014.12.002 .
doi: 10.1016/j.surg.2014.12.002
pubmed: 25704426
Xu D, Wu P, Zhang K, et al. The short-term outcomes of distal pancreatectomy with portal vein/superior mesenteric vein resection. Langenbeck’s Arch Surg. 2022;407(5):2161–8. https://doi.org/10.1007/s00423-021-02382-8 .
doi: 10.1007/s00423-021-02382-8
Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161(3):584–91. https://doi.org/10.1016/j.surg.2016.11.014 .
doi: 10.1016/j.surg.2016.11.014
pubmed: 28040257
Watanabe G, Ito H, Sato T, et al. Left kidney mobilization technique during radical antegrade modular pancreatosplenectomy (RAMPS). Langenbecks Arch Surg. 2019;404(2):247–52. https://doi.org/10.1007/s00423-019-01767-0 .
doi: 10.1007/s00423-019-01767-0
pubmed: 30810806
Sato T, Saiura A, Inoue Y, Takahashi Y, Arita J, Takemura N. Distal pancreatectomy with en bloc resection of the celiac axis with preservation or reconstruction of the left gastric artery in patients with pancreatic body cancer. World J Surg. 2016;40(9):2245–53. https://doi.org/10.1007/s00268-016-3550-x .
doi: 10.1007/s00268-016-3550-x
pubmed: 27198999
Sato T, Inoue Y, Takahashi Y, et al. Distal pancreatectomy with celiac axis resection combined with reconstruction of the left gastric artery. J Gastrointest Surg. 2017;21(5):910–7. https://doi.org/10.1007/s11605-017-3366-5 .
doi: 10.1007/s11605-017-3366-5
pubmed: 28116666
Oba A, Inoue Y, Sato T, et al. Impact of indocyanine green-fluorescence imaging on distal pancreatectomy with celiac axis resection combined with reconstruction of the left gastric artery. HPB (Oxford). 2019;21(5):619–25. https://doi.org/10.1016/j.hpb.2018.09.023 .
doi: 10.1016/j.hpb.2018.09.023
pubmed: 30401519
Inoue Y, Saiura A, Sato T, et al. Details and outcomes of distal pancreatectomy with celiac axis resection preserving the left gastric arterial flow. Ann Surg Oncol. 2021;28(13):8283–94. https://doi.org/10.1245/s10434-021-10243-3 .
doi: 10.1245/s10434-021-10243-3
pubmed: 34143337
Bockhorn M, Uzunoglu FG, Adham M, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2014;155(6):977–88. https://doi.org/10.1016/j.surg.2014.02.001 .
doi: 10.1016/j.surg.2014.02.001
pubmed: 24856119
Isaji S. [Revised 7th edition of the General Rules for the Study of Pancreatic Cancer by Japan Pancreas Society: Revised concepts and updated points. Nihon Shokakibyo Gakkai Zasshi. 2017;114(4):617–26. https://doi.org/10.11405/nisshoshi.114.617 .
doi: 10.11405/nisshoshi.114.617
pubmed: 28381778
Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic adenocarcinoma, Version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(4):439–57. https://doi.org/10.6004/jnccn.2021.0017 .
doi: 10.6004/jnccn.2021.0017
pubmed: 33845462
Schwartz LH, Litiere S, de Vries E, et al. RECIST 1.1-Update and clarification: from the RECIST committee. Eur J Cancer. 2016;62:132–7. https://doi.org/10.1016/j.ejca.2016.03.081 .
doi: 10.1016/j.ejca.2016.03.081
pubmed: 27189322
pmcid: 5737828
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96. https://doi.org/10.1097/SLA.0b013e3181b13ca2 .
doi: 10.1097/SLA.0b013e3181b13ca2
pubmed: 19638912
Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transpl. 2013;48(3):452–8. https://doi.org/10.1038/bmt.2012.244 .
doi: 10.1038/bmt.2012.244
Bell R, Ao BT, Ironside N, Bartlett A, Windsor JA, Pandanaboyana S. Meta-analysis and cost effective analysis of portal-superior mesenteric vein resection during pancreatoduodenectomy: Impact on margin status and survival. Surg Oncol. 2017;26(1):53–62. https://doi.org/10.1016/j.suronc.2016.12.007 .
doi: 10.1016/j.suronc.2016.12.007
pubmed: 28317585
Zhou Y, Zhang Z, Liu Y, Li B, Xu D. Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis. World J Surg. 2012;36(4):884–91. https://doi.org/10.1007/s00268-012-1461-z .
doi: 10.1007/s00268-012-1461-z
pubmed: 22350478
Miyazaki M, Shimizu H, Ohtuka M, et al. Portal vein thrombosis after reconstruction in 270 consecutive patients with portal vein resections in hepatopancreatobiliary (HPB) surgery. Am J Surg. 2017;214(1):74–9. https://doi.org/10.1016/j.amjsurg.2016.12.008 .
doi: 10.1016/j.amjsurg.2016.12.008
pubmed: 28069106
Hackert T, Klaiber U, Hinz U, et al. Portal vein resection in pancreatic cancer surgery: risk of thrombosis and radicality determine survival. Ann Surg. 2022. https://doi.org/10.1097/SLA.0000000000005444 .
doi: 10.1097/SLA.0000000000005444
pubmed: 35861061
Chan KS, Srinivasan N, Koh YX, et al. Comparison between long and short-term venous patencies after pancreatoduodenectomy or total pancreatectomy with portal/superior mesenteric vein resection stratified by reconstruction type. PLoS One. 2020;15(11):e0240737. https://doi.org/10.1371/journal.pone.0240737 .
doi: 10.1371/journal.pone.0240737
pubmed: 33151977
pmcid: 7644060
McMillan MT, Christein JD, Callery MP, et al. Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy. Surgery. 2016;159(4):1013–22. https://doi.org/10.1016/j.surg.2015.10.028 .
doi: 10.1016/j.surg.2015.10.028
pubmed: 26670325
Torgeson A, Lloyd S, Boothe D, et al. Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer. Cancer. 2017;123(19):3816–24. https://doi.org/10.1002/cncr.30780 .
doi: 10.1002/cncr.30780
pubmed: 28621885
Blair AB, Sorber R, Rozich NS, Burkhart RA. A qualitative review of neoadjuvant chemotherapy in resectable pancreatic adenocarcinoma. Pancreas. 2019;48(8):973–84. https://doi.org/10.1097/MPA.0000000000001376 .
doi: 10.1097/MPA.0000000000001376
pubmed: 31425483
Kang MJ, Jang JY, Chang YR, Jung W, Kim SW. Portal vein patency after pancreatoduodenectomy for periampullary cancer. Br J Surg. 2015;102(1):77–84. https://doi.org/10.1002/bjs.9682 .
doi: 10.1002/bjs.9682
pubmed: 25393075
Okusaka T, Furuse J. Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelines. J Gastroenterol. 2020;55(4):369–82. https://doi.org/10.1007/s00535-020-01666-y .
doi: 10.1007/s00535-020-01666-y
pubmed: 31997007
pmcid: 7080663